Accessibility Tools

Select your language

Select your language

Simple, single-colour grey vector representation of the Bremen skyline with prominent buildings such as St. Petri Cathedral and TV tower, windmill and other urban structures on a light background.

Welcome the website of the Bremen Cancer Registry!

One in two men and about 40 percent of women develop cancer in the course of their lives and every year about 220,000 people die as a result of cancer. In this context, systematic monitoring of cancer incidence is of great social importance. Comprehensive and complete cancer registration is crucial to facilitate further progress in the prevention, early detection and treatment of cancer.

As the clinical-epidemiological cancer registry of the state of Bremen, we process area-wide inpatient and outpatient data on the occurrence, treatment and courses of tumor diseases. These data are regularly analyzed and evaluated. Not only patients but also treating physicians, health insurance providers as well as political decision makers benefit from this. Therefore, the registry is also a firm partner of science and involved in numerous important studies.

Cancer in Bremen

Every year, almost 4,200 Bremen residents are newly diagnosed with cancer. With a population of about 680,000, the crude ratio in Bremen is about 610 cases per 100,000 inhabitants. In addition, there are about 1,200 further patients diagnosed with non-melanotic skin tumors. These tumors are characterized by a very good prognosis and are therefore not counted in cancer reporting according to international practice.

The risk of developing cancer increases with age. The mean age of onset is 71 years for women and 72 years for men. Less than 10 percent of cancer cases occur before the age of 50. The chance of surviving cancer depends strongly on the type of cancer. Regarding all cancers, the proportion of survivors five years after diagnosis is approximately 60 percent. Cancer is the second most common cause of death in Bremen with about 2,000 deaths annually.

View of Bremen's market square with historic gabled houses, Liebfrauenkirche and the town hall under blue skies.

Current news

October 14, 2026

New Quality Assurance Procedure for Prostate Cancer

The new quality assurance procedure for locally confined prostate cancer (QS Prostate-Ca) is scheduled to launch nationwide on January 1, 2027. The IQTIG has provided an informational letter on this topic and invites all urologists and radiation therapists to an online informational session.

September 29, 2026

New newsletter

The new newsletter for the third quarter 2026 of the Bremen Cancer Registry is now available.

September 22, 2026

CancerQualityHub 2026

This year's CancerQualityHub focusing on colorectal cancer will take place on November 26, 2026. The program and the link for registration can be found online on the website of the GNCR.

August 26, 2026

New online reports

The residence-based epidemiological report has been updated. In addition, a clinical report based on the location of treatment is now available. You will find brief descriptions and links to both reports under Data Analysis → Interactive Online Reports.

Leibniz Institute for Prevention Research and Epidemiology - BIPS
The Senator for Health, Women and Consumer Protection